CSF2 — Colony Stimulating Factor 2 (GM-CSF)

CSF2 — Colony Stimulating Factor 2 (GM-CSF)

Overview

CSF2 (Colony Stimulating Factor 2), also known as Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), is a cytokine-encoding gene located on chromosome 5q31.1. This gene encodes a hematopoietic growth factor that stimulates the production and differentiation of granulocytes and macrophages from bone marrow progenitor cells. In the central nervous system, CSF2 plays complex roles in both immune function and neuronal survival. The gene is expressed in various brain cell types including [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation), and endothelial cells, where it can promote neuroinflammation through microglial activation while also exhibiting neurotrophic properties. CSF2 has been investigated for potential therapeutic benefits in neurodegenerative diseases, with clinical trials exploring its effects on cognitive function in Alzheimer's disease. However, the dual nature of CSF2/GM-CSF action—promoting both beneficial neurotrophic effects and potentially harmful neuroinflammation—makes its therapeutic modulation complex. [@gmcsf_function]

CSF2 — Colony Stimulating Factor 2 (GM-CSF)

Overview

CSF2 (Colony Stimulating Factor 2), also known as Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), is a cytokine-encoding gene located on chromosome 5q31.1. This gene encodes a hematopoietic growth factor that stimulates the production and differentiation of granulocytes and macrophages from bone marrow progenitor cells. In the central nervous system, CSF2 plays complex roles in both immune function and neuronal survival. The gene is expressed in various brain cell types including [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation), and endothelial cells, where it can promote neuroinflammation through microglial activation while also exhibiting neurotrophic properties. CSF2 has been investigated for potential therapeutic benefits in neurodegenerative diseases, with clinical trials exploring its effects on cognitive function in Alzheimer's disease. However, the dual nature of CSF2/GM-CSF action—promoting both beneficial neurotrophic effects and potentially harmful neuroinflammation—makes its therapeutic modulation complex. [@gmcsf_function]

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Colony Stimulating Factor 2</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>CSF2</td></tr>
<tr><td><strong>Full Name</strong></td><td>Colony stimulating factor 2 (GM-CSF)</td></tr>
<tr><td><strong>Chromosome</strong></td><td>5q31.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1437](https://www.ncbi.nlm.nih.gov/gene/1437)</td></tr>
<tr><td><strong>OMIM</strong></td><td>138960</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000164400</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P04141](https://www.uniprot.org/uniprot/P04141)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, ALS, Multiple Sclerosis</td></tr>
</table>
</div>

Gene Structure and Molecular Biology

Gene Organization

The CSF2 gene spans approximately 2.5 kb and consists of 4 exons encoding a 144-amino acid precursor protein. The gene is located on chromosome 5q31.1, a region that also contains other cytokine genes including [IL3](/entities/il3) and [IL5](/entities/il5), forming a cytokine cluster. The promoter region contains multiple transcription factor binding sites, including those for NF-κB, AP-1, and STAT5, allowing for complex regulation in response to various inflammatory stimuli. [@gmcsf_function]

Protein Structure

The mature CSF2 protein is a 14 kDa glycoprotein that exists as a monomer in solution but forms a biologically active dimer upon binding to its receptor. The protein contains:

Biosynthesis and Secretion

CSF2 is produced by multiple cell types:

• Macrophages and Monocytes: Primary cellular sources
• T Lymphocytes: Upon activation
• Fibroblasts: In response to inflammatory signals
• Endothelial Cells: In vasculature and brain
• Neurons: Low-level expression in CNS
• Astrocytes: Inducible expression
• Microglia: Constitutive and inducible expression

Receptor Signaling

GM-CSF Receptor Complex

CSF2 signals through a heterodimeric receptor complex consisting of:

The receptor is expressed on:

• Myeloid progenitors (promyelocytes, myelocytes)
• Mature granulocytes and macrophages
• Monocytes and dendritic cells
• Some neuronal and glial populations in the brain
• Endothelial cells

Signaling Pathways

Upon ligand binding, CSF2RA and CSF2RB dimerize, triggering multiple downstream signaling cascades:

JAK-STAT Pathway

• JAK2 associates with the beta chain
• STAT5 (primarily STAT5A and STAT5B) phosphorylation
• Dimerization and nuclear translocation
• Transcription of target genes including SOCS proteins

• PI3K activation via p85 subunit recruitment
• AKT phosphorylation and activation
• Cell survival and metabolic regulation
• mTOR pathway activation

• RAS activation
• RAF, MEK, and ERK phosphorylation
• Cell proliferation and differentiation
• Integration with other signaling cascades

• IKK complex activation
• IκB degradation
• NF-κB nuclear translocation
• Pro-inflammatory gene transcription

Expression in the Central Nervous System

Cellular Distribution

CSF2 expression in the brain is more complex than initially appreciated:

Microglia

• Express both CSF2RA and CSF2RB
• Respond to CSF2 with enhanced phagocytosis
• Produce pro-inflammatory cytokines in response
• Role in synaptic pruning and remodeling
• [@gmcsf_microglia]

• Produce CSF2 under inflammatory conditions
• Express CSF2RA for autocrine signaling
• Support neuronal survival in some contexts
• Participate in reactive astrogliosis

• Lower but detectable expression
• May provide trophic support
• Potential neuroprotective effects
• Role in neuronal plasticity

• CSF2 production at the blood-brain barrier
• Regulation of immune cell trafficking
• Potential for CNS immune surveillance

Regulation in the Brain

CSF2 expression in the CNS is modulated by:

• Pro-inflammatory Cytokines: IL-1β, TNF-α, IFN-γ enhance expression
• Microbial Products: LPS via TLR4 activation
• Damage-Associated Molecular Patterns (DAMPs)
• Neuronal Activity: Activity-dependent regulation
• Aging: Altered expression patterns with age

Role in Neurodegenerative Diseases

Alzheimer's Disease

CSF2 presents a complex dual role in Alzheimer's disease pathogenesis:

Pro-inflammatory Effects

• Enhances microglial activation
• Increases pro-inflammatory cytokine production (IL-1β, TNF-α, IL-6)
• May accelerate amyloid-beta deposition
• Promotes chronic neuroinflammation
• Contributes to neuronal dysfunction

• Promotes microglial phagocytosis of Aβ
• Enhances Aβ clearance
• Supports neuronal survival
• May improve synaptic function
• Clinical trials show cognitive improvement

• Timing of intervention (early vs. late)
• Dose-dependent effects
• Balance between inflammatory and clearance functions
• Individual genetic variation

• CSF2 polymorphisms have been studied in AD
• Some variants may influence disease risk
• Haplotypes with altered expression patterns
• [@gmcsf_ad_therapy]

Parkinson's Disease

In Parkinson's disease, CSF2 exhibits context-dependent effects:

Neuroinflammation Modulation

• Activates microglia in the substantia nigra
• May contribute to dopaminergic neuron loss
• Chronic activation promotes progression

• Some studies show trophic effects
• May protect dopaminergic neurons
• Potential for disease modification

• Animal models show conflicting results
• Timing and dose critical
• Synergy with other growth factors
• [@gmcsf_pd]

Amyotrophic Lateral Sclerosis (ALS)

CSF2 dysregulation is observed in ALS:

Motor Neuron Environment

• Increased CSF2 in CSF of ALS patients
• Microglial activation in disease models
• SOD1 mice show altered CSF2 responses

• GM-CSF receptor as potential target
• Modulation may modify disease course
• Clinical trials of GM-CSF in ALS planned
• [@gmcsf_als]

Multiple Sclerosis

CSF2 plays a complex role in demyelinating disease:

Pro-inflammatory Effects

• Promotes expansion of myeloid cells
• Enhances antigen presentation
• May exacerbate autoimmune responses

• Some studies show oligodendrocyte progenitor stimulation
• Potential for repair mechanisms
• Dual nature complicates targeting
• [@gmcsf_ms]

Therapeutic Implications

GM-CSF as a Therapeutic Agent

Rationale for Use

• Enhancement of Aβ clearance
• Cognitive improvement in clinical trials
• Neurotrophic effects
• Support of brain immune function

• Phase 2 trial showed cognitive benefits
• Improved memory and function scores
• Generally well-tolerated
• Mechanism under investigation

• Optimal dose unclear
• Chronic vs. acute administration
• Individual variation in response

GM-CSF as a Therapeutic Target

Antagonist Approaches

• Neutralizing antibodies
• Soluble receptors
• Small molecule inhibitors
• Used in autoimmune conditions

• May reduce harmful inflammation
• Could impair beneficial functions
• Balance is critical

Drug Development

Agonists

• Recombinant GM-CSF (sargramostim)
• Modified variants with enhanced activity
• Novel delivery methods

• Anti-GM-CSF antibodies (lenzilumab)
• GM-CSF receptor blockers
• Small molecule inhibitors

Disease Associations

| Disease | Variants | Inheritance | Mechanism |
|---------|----------|-------------|-----------|
| Alzheimer's Disease | Various | Risk factor | Microglial activation, neuroinflammation, Aβ clearance |
| Parkinson's Disease | Various | Risk factor | Neuroinflammation, dopaminergic neuron survival |
| ALS | Various | Risk factor | Microglial activation, motor neuron inflammation |
| Multiple Sclerosis | Various | Risk factor/Protection | Autoimmune demyelination, potential repair |

Signaling Pathways in Neurodegeneration

origin/main
K --> P

Pathway Diagram

The following diagram shows the key molecular relationships involving CSF2 — Colony Stimulating Factor 2 (GM-CSF) discovered through SciDEX knowledge graph analysis: